
Christoffer R. Gebhardt
Hamburg, HH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 143 publications
Beyond the First Graft: Skin Cancer Risk and Risk Stratification in Retransplanted Solid Organ Recipients.
Journal: The British journal of dermatology
Published: May 05, 2026
primary analysis of the RANDOMIZED eortc-2139/columbus-ad trial: Adjuvant encorafenib and binimetinib versus placebo in high-risk stage II BRAF-V600E/K melanoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 16, 2026
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention - Update 2026.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 19, 2026
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment - update 2026.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 19, 2026
Circulating Tumor DNA as a Biomarker for Melanoma Prognosis and Therapy.
Journal: American journal of clinical dermatology
Published: March 02, 2026
Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study.
Journal: Journal for immunotherapy of cancer
Published: February 23, 2026
Real-world treatment patterns in stage III and IV melanoma patients: insights from a global multi-center chart review study.
Journal: Frontiers in immunology
Published: February 18, 2026
Unraveling the Plasma Extracellular Vesicles Proteome: Predictors of Resistance in Immunotherapy of Advanced Melanoma.
Journal: International journal of cancer
Published: February 18, 2026
Synergistic effects of anticoagulants and platelet aggregation inhibitors with immune checkpoint inhibitors in cancer therapy: a comprehensive review of preclinical and clinical evidence.
Journal: Journal for immunotherapy of cancer
Published: January 16, 2026
Treatment patterns in geriatric patients with melanoma and the effect of age on the efficacy of immunotherapy: Analysis from the real-world multicenter registry ADOREG.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 16, 2026
Translating ctDNA into cutaneous melanoma care: An international expert survey.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 13, 2026
COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant Melanoma.
Journal: Cancers
Published: January 13, 2026
Last Updated: 09/26/2026